DATA SOURCES

NameData typesVersionLast update
cancer.gov Drug Indications 2/27/2021
clinicaltrials.gov Clinical Trials 2/27/2021
PDB 3D Crystal Structures 2/23/2021
UniProt Proteins 2021_01 2/10/2021
canSAR Approved Drug Curation 1/4/2021
IMEx Interactions 11/10/2020
Phosphosite Interactions 11/2/2020
Other trusted sources and publications Interactions 10/14/2020
ChEMBL Compounds, Bioactivity Data ChEMBL_27 5/18/2020
CCSB Interactions HI-union 4/8/2020

DATA COUNTS

Type#
Proteins
20,396 human, 564,407 all species
3D Structures
173,663 structures, 509,182 chains
Compounds
3,128,263 unique structures
Organisms
2,148
Chemical Bioactivities
8,039,118 datapoints from 66,066 studies
Clinical Trials
368,905
Cancer studies
TCGA: 33
ICGC: 61
Samples
Primary: 19,244
Metastasized: 1,782
Pediatric: 4,211
Interactions by host
1,001,674 (human)
4,032 (coronavirus-human)
2,429 (Cov2)
1,150 (SARS)
309 (MERS)
144 (other coronavirus)
Interactions by type
Signalling pathways: 102,818
Enzymatic reactions: 8,831
Direct binding: 138,107
In same complex: 388,337
Transcriptional: 117,420
Drug Synergies: 12,118
Low confidence complex: 238,240